TVRD
Tvardi Therapeutics, Inc. - Common Stock (TVRD)
$90
About Tvardi Therapeutics, Inc. - Common Stock (TVRD)
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
Details
Daily high
$1.91
Daily low
$1.81
Price at open
$1.89
52 Week High
$43.65
52 Week Low
$1.50
Market cap
17.4M
Dividend yield
-
Volume
2,204
Avg. volume
434,072
P/E ratio
-.67
Tvardi Therapeutics, Inc. - Common Stock News
Details
Daily high
$1.91
Daily low
$1.81
Price at open
$1.89
52 Week High
$43.65
52 Week Low
$1.50
Market cap
17.4M
Dividend yield
-
Volume
2,204
Avg. volume
434,072
P/E ratio
-.67